A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasis
Spelman, Lynda, Rubel, Diana, Brnabic, Alan, Burkhardt, Nicole, Riedl, Elisabeth, Foley, PeterJournal:
Journal of Dermatological Treatment
DOI:
10.1080/09546634.2020.1752888
Date:
April, 2020
File:
PDF, 1.38 MB
2020